DEBRA News: Research
Spray-on Gene Therapy with RenovaCare SkinGun™ in New Study Underway at King’s College London
7 April 2020
RenovaCare Inc. have announced that the Company’s novel SkinGun™ is now being used to apply regenerative cells in a preclinical study of new gene therapies, underway at King’s College London.
Researcher Dr Maria Papanikolaou collaborates with DEBRA UK to visit the Miami Itch Center
29 January 2020
Dr Maria Papanikolaou shares her experience of visiting the Miami Itch Center with the support of DEBRA UK. Dr Papanikolaou is currently working on the PRUMEC trial, which focuses on explaining the cause of itch in an inherited skin condition known as Dystrophic Epidermolysis Bullosa.
DEBRA Funds 4th year towards Novel Gene Technology for Epidermolysis Bullosa
1 October 2019
We are pleased to announce funding for a fourth year of the University of Dundee’s research into novel gene technology for treating Epidermolysis Bullosa has been agreed.
Merger of US Pharmaceutical and Cell & Gene Therapy companies has potential to develop multiple promising new therapies
20 September 2019
The announcement several days ago of a merger of two US companies in the field of dermatology and cell and gene therapy is very positive news for the future development of therapies and products for EB.
New Research Supports EB Cancer Trial
12 April 2019
New research suggests Rigosertib may be safe and effective in combating EB cancer. We’re funding a clinical trial to take it to the next stage.
Make a difference
Please help us fund vital healthcare such as specialist EB nurses as well as research, care and life-changing support.